Article
The role of lipid signaling in the progression of malignant melanoma.
Cancer metastasis reviews - 1 Sept 2018
Tímár József, Hegedüs B, Rásó E
Abstract excerpt
In the past decades, a vast amount of data accumulated on the role of lipid signaling pathways in the progression of malignant melanoma, the most metastatic/aggressive human cancer type. Genomic studies identified that PTEN loss is the leading factor behind the activation of the PI3K-signaling pathway in melanoma, mutations of which are one of the main resistance mechanisms behind target therapy failures. On the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
